SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer announces unaudited standalone results

30 Jan 2017 Evaluate

Pfizer has announced the Unaudited Standalone results for the quarter ended December 31, 2016. The Company has posted a net profit of Rs 623.70 million for the quarter ended December 31, 2016 as compared to Rs 597.60 million for the quarter ended December 31, 2015. Total Income has decreased from Rs 5509.60 million for the quarter ended December 31, 2015 to Rs 5367.50 million for the quarter ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Pfizer Share Price

4853.90 42.85 (0.89%)
11-May-2026 12:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1877.10
Dr. Reddys Lab 1289.65
Cipla 1326.30
Zydus Lifesciences 946.80
Lupin 2263.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×